Published 1992 | Version v1
Book

Dose-response analysis for boron neutron capture therapy of the B16 murine melanoma using p-boronophenylalanine

  • 1. Brookhaven National Lab., Upton, NY (United States)

Description

Boron Neutron Capture Therapy (BNCT) of a well-pigmented B16 melanoma implanted subcutaneously in the mouse thigh has been carried out at the Brookhaven Medical Research Reactor (BMRR) using the synthetic amino acid p-boronophenylalanine (BPA) as the boron delivery agent. The response of the B16 melanoma to BNCT was compared with the response to 250 kVp x-rays using both tumor growth delay and an in vivo/in vitro assay that measures clonogenic survival. These experiments allow a comparison of tumor growth delay, log cell kill and damage to normal tissues produced by BNCT or photon irradiation

Additional details

Publishing Information

Publisher
Plenum Press.
Imprint Place
New York, NY (United States)
Imprint Title
Progress in neutron capture therapy for cancer
Imprint Pagination
668 p.
Journal Page Range
p. 417-419.

Conference

Title
4. international symposium on neutron capture therapy for cancer.
Dates
4-7 Dec 1990.
Place
Sydney (Australia).